看moderna公司的回复： Moderna cautioned against comparing its vaccine, saying the trials for the rival shots used different case definitions for RSV-disease.
"In the absence of head-to-head clinical trials, comparative conclusions regarding the safety and efficacy of mRNA-1345 relative to other RSV vaccines cannot be made," Moderna said.